Contraceptive Technology Update
RSSArticles
-
STD Quarterly: CTUpdates
Mark your calendars for the Contraceptive Technology Quest for Excellence conference, set for Nov. 11-12 in Atlanta. -
STD Quarterly: Treatment alert for sexually transmitted diseases: Check use of azithromycin for early syphilis
Clinicians who opt to use azithromycin for treatment of early syphilis should review recently published research that indicates that at least 10% of syphilis samples from patients at sexually transmitted disease (STD) clinics in four cities had a strain resistant to the antibiotic. -
Latest research sheds new light on DMPA’s impact on bone health
Your next patient is a 17-year-old who admits she has a hard time remembering to take the Pill, but says she wants to avoid unintended pregnancy. When you begin to counsel on the injectable contraceptive Depo Provera [depot medroxyprogesterone acetate (DMPA), Pfizer, New York City], what do you tell her about the drug?